The global Network Point of Care Glucose Testing Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (i-STAT, Accu-Chek Inform II, StatStrip, HemoCue, CareSens Expert Plus, BAROzen H Expert Plus).
Revolutionizing diabetes management and glycemic control, the Network Point-of-Care Glucose Testing market offers integrated systems enabling real-time glucose monitoring and data sharing in clinical settings. Network point-of-care glucose testing platforms connect glucometers, continuous glucose monitors (CGMs), and electronic health records (EHRs), facilitating seamless communication between patients, healthcare providers, and care teams for timely intervention and personalized diabetes care. The market's growth is driven by the rising prevalence of diabetes, advancements in glucose monitoring technology, and initiatives promoting remote patient monitoring and telehealth in diabetes management.
A significant trend in the network point of care glucose testing market is the integration of connectivity and data management solutions. As healthcare systems continue to embrace digitalization and remote patient monitoring, there's a growing demand for point-of-care glucose testing devices that can seamlessly integrate with electronic health records (EHRs), hospital information systems (HIS), and other networked platforms. Manufacturers are developing glucose testing devices equipped with wireless connectivity features, such as Bluetooth and Wi-Fi, allowing for real-time data transmission and remote monitoring of patients' glucose levels. Additionally, cloud-based data management solutions enable healthcare providers to access and analyze glucose testing results from multiple locations, enhancing care coordination and clinical decision-making. This trend towards connectivity and data integration is driving market growth and shaping the future of network point of care glucose testing.
The primary driver propelling the network point of care glucose testing market is the rising prevalence of diabetes and the need for timely monitoring of blood glucose levels. Diabetes is a global epidemic, with millions of people worldwide living with the condition and millions more at risk of developing it. Effective management of diabetes relies on regular monitoring of blood glucose levels to prevent complications such as hyperglycemia, hypoglycemia, and diabetic ketoacidosis. Point-of-care glucose testing devices offer convenient and timely monitoring solutions, allowing patients and healthcare providers to make informed decisions about diabetes management, medication dosing, and lifestyle modifications. As the burden of diabetes continues to increase, there's a corresponding rise in the demand for networked glucose testing solutions that enable seamless data sharing, remote monitoring, and personalized care delivery, driving market demand and adoption.
An exciting opportunity in the network point of care glucose testing market lies in the expansion into home healthcare and remote monitoring applications. While point-of-care glucose testing has traditionally been performed in clinical settings, there's a growing trend towards home-based monitoring and self-management of diabetes. Manufacturers can capitalize on this opportunity by developing user-friendly and portable glucose testing devices that are suitable for home use, incorporating features such as smartphone connectivity, intuitive interfaces, and remote data sharing capabilities. Additionally, remote monitoring solutions enable healthcare providers to monitor patients' glucose levels and provide timely interventions and support, particularly for individuals with complex medical needs or limited access to healthcare facilities. By expanding into home healthcare and remote monitoring applications, manufacturers can address unmet patient needs, improve diabetes management outcomes, and differentiate their offerings in the competitive network point of care glucose testing market.
By Product
i-STAT
Accu-Chek Inform II
StatStrip
HemoCue
CareSens Expert Plus
BAROzen H Expert Plus
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Abbott
Bayer AG
Danaher
F. Hoffmann-La Roche Ltd
Nova Biomedical
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Network Point of Care Glucose Testing Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Network Point of Care Glucose Testing Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Network Point of Care Glucose Testing Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Network Point of Care Glucose Testing Market Size Outlook, $ Million, 2021 to 2030
3.2 Network Point of Care Glucose Testing Market Outlook by Type, $ Million, 2021 to 2030
3.3 Network Point of Care Glucose Testing Market Outlook by Product, $ Million, 2021 to 2030
3.4 Network Point of Care Glucose Testing Market Outlook by Application, $ Million, 2021 to 2030
3.5 Network Point of Care Glucose Testing Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Network Point of Care Glucose Testing Industry
4.2 Key Market Trends in Network Point of Care Glucose Testing Industry
4.3 Potential Opportunities in Network Point of Care Glucose Testing Industry
4.4 Key Challenges in Network Point of Care Glucose Testing Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Network Point of Care Glucose Testing Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Network Point of Care Glucose Testing Market Outlook by Segments
7.1 Network Point of Care Glucose Testing Market Outlook by Segments, $ Million, 2021- 2030
By Product
i-STAT
Accu-Chek Inform II
StatStrip
HemoCue
CareSens Expert Plus
BAROzen H Expert Plus
8 North America Network Point of Care Glucose Testing Market Analysis and Outlook To 2030
8.1 Introduction to North America Network Point of Care Glucose Testing Markets in 2024
8.2 North America Network Point of Care Glucose Testing Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Network Point of Care Glucose Testing Market size Outlook by Segments, 2021-2030
By Product
i-STAT
Accu-Chek Inform II
StatStrip
HemoCue
CareSens Expert Plus
BAROzen H Expert Plus
9 Europe Network Point of Care Glucose Testing Market Analysis and Outlook To 2030
9.1 Introduction to Europe Network Point of Care Glucose Testing Markets in 2024
9.2 Europe Network Point of Care Glucose Testing Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Network Point of Care Glucose Testing Market Size Outlook by Segments, 2021-2030
By Product
i-STAT
Accu-Chek Inform II
StatStrip
HemoCue
CareSens Expert Plus
BAROzen H Expert Plus
10 Asia Pacific Network Point of Care Glucose Testing Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Network Point of Care Glucose Testing Markets in 2024
10.2 Asia Pacific Network Point of Care Glucose Testing Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Network Point of Care Glucose Testing Market size Outlook by Segments, 2021-2030
By Product
i-STAT
Accu-Chek Inform II
StatStrip
HemoCue
CareSens Expert Plus
BAROzen H Expert Plus
11 South America Network Point of Care Glucose Testing Market Analysis and Outlook To 2030
11.1 Introduction to South America Network Point of Care Glucose Testing Markets in 2024
11.2 South America Network Point of Care Glucose Testing Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Network Point of Care Glucose Testing Market size Outlook by Segments, 2021-2030
By Product
i-STAT
Accu-Chek Inform II
StatStrip
HemoCue
CareSens Expert Plus
BAROzen H Expert Plus
12 Middle East and Africa Network Point of Care Glucose Testing Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Network Point of Care Glucose Testing Markets in 2024
12.2 Middle East and Africa Network Point of Care Glucose Testing Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Network Point of Care Glucose Testing Market size Outlook by Segments, 2021-2030
By Product
i-STAT
Accu-Chek Inform II
StatStrip
HemoCue
CareSens Expert Plus
BAROzen H Expert Plus
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott
Bayer AG
Danaher
F. Hoffmann-La Roche Ltd
Nova Biomedical
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
i-STAT
Accu-Chek Inform II
StatStrip
HemoCue
CareSens Expert Plus
BAROzen H Expert Plus
The global Network Point of Care Glucose Testing Market is one of the lucrative growth markets, poised to register a 4.5% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Abbott, Bayer AG, Danaher, F. Hoffmann-La Roche Ltd, Nova Biomedical
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume